AerCap Holdings N.V. ("AerCap" or the "Company") (NYSE: AER) has announced today that AerCap Ireland Capital Designated Activity Company and AerCap Global Aviation Trust (together, the "Issuers"), each a wholly-owned subsidiary of the Company, priced their offering of senior notes, consisting of $1.250 billion aggregate principal amount of 6.50% Senior Notes due 2025 (the "Notes"). The Notes will be fully and unconditionally guaranteed on a senior unsecured basis by the Company and certain other subsidiaries of the Company. The Issuers intend to use the net proceeds from the Notes for general corporate purposes.
Uber Technologies Inc said on Wednesday trip requests were gradually picking up, but still remained significantly below prior year levels, as several countries start to lift coronavirus-led restrictions. Trip requests are now down about 70% from a year earlier, slightly lesser than April's 80% drop, Chief Executive Officer Dara Khosrowshahi said in a conference with Bank of America analysts.
Abiomed will hold a fireside chat at the William Blair 40th Annual Growth Stock Conference (virtual).
General Mills, Inc. (NYSE: GIS) plans to report results for its fiscal 2020 fourth quarter and full year on Wednesday, July 1, 2020. A press release will be issued that morning, followed by a webcast conference call of those results beginning at 7:30 a.m. CT (8:30 a.m. ET). Interested investors can access this webcast and supporting slides at www.generalmills.com/investors.
Pfizer Inc. (NYSE: PFE) announced today that JAMA Dermatology has published complete results from the second Phase 3 monotherapy pivotal study (JADE MONO-2) of abrocitinib, an investigational oral once-daily Janus kinase 1 (JAK1) inhibitor, in patients aged 12 and older with moderate to severe atopic dermatitis (AD). Consistent with the first Phase 3 monotherapy study (JADE MONO-1), both doses of abrocitinib met all co-primary and key secondary endpoints and were generally well tolerated.
Leidos (NYSE:LDOS), a FORTUNE® 500 science and technology leader, has been awarded a new prime contract to provide information technology operations and maintenance support services to the Defense Intelligence Agency (DIA). The competitive task order, awarded under DIA's ESITE indefinite delivery/indefinite quantity, cost-plus-award-fee contract has a five month base period of performance followed by five one-year option periods and a final 6-month option period. The contract holds a value of $401 million if all options are exercised. Work will be performed primarily at DIA headquarters at Joint Base Anacostia-Bolling Washington, DC and at Leidos facilities.
The US Department of Justice today joined a newly unsealed whistleblower lawsuit filed by Phillips & Cohen LLP that alleges AECOM and certain institutions in New Orleans cheated the Federal Emergency Management Agency out of more than $100 million in disaster relief funds by repeatedly submitting fraudulent information in violation of FEMA rules.
Curtiss-Wright Corporation (NYSE: CW) today announced that David C. Adams, Chairman and Chief Executive Officer, K. Christopher Farkas, Vice President and Chief Financial Officer, Lynn M. Bamford, President, Defense and Power Segments, and Kevin M. Rayment, President, Commercial / Industrial Segment, will participate virtually in the Stifel 2020 Cross Sector Insight Conference on Wednesday, June 10, 2020. A fireside chat discussion will take place at 8:00 am ET.
NexTier Oilfield Solutions Inc. (NYSE: NEX) ("NexTier" or the "Company") today announced that members of its management team plan to participate in the following upcoming virtual investor conferences:
The Global Transfection Reagents and Equipment Market will grow by USD 319.58 mn during 2020-2024
Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and sustainability industries, and Emalex Biosciences, Inc. ("Emalex"), a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system movement disorders and fluency disorders, announced today a $15 million venture loan facility to advance Emalex's development programs through clinical trials.
Semtech Corporation (Nasdaq: SMTC), a leading supplier of high performance analog and mixed signal semiconductors and advanced algorithms, today announced that its Chief Financial Officer Emeka Chukwu, will participate in a virtual fireside chat during the Stifel 2020 Virtual Cross Sector Insight Conference scheduled for Wednesday, June 10th, 2020 at 1:20 p.m. EDT. A webcast of the event and a replay will be accessible via the Investor Relations section of Semtech’s corporate website at http://investors.semtech.com/events.cfm.
Shares of Smartsheet Inc. were off 15% in after-hours trading Wednesday after the company fell short of expectations with its fiscal first-quarter billings and gave a weaker-than-anticipated outlook for the current period. The company posted a net loss of $27.8 million, or 23 cents a share, compared with a loss of $19.8 million, or 19 cents a share, in the year-prior quarter. Smartsheet reported an adjusted loss per share of 11 cents, compared with 12 cents a year earlier and the 19 cents that analysts surveyed by FactSet had been projecting. Smartsheet's revenue grew to $85.5 million, up from $56.2 million a year prior, while analysts had been calling for $81.3 million. Calculated billings for the fiscal first quarter rose to $89.9 million from $69.1 million, while analysts were expecting $94.1 million. For the fiscal second quarter, Smartsheet expects $86 million to $87 million in revenue and an adjusted net loss of 16 cents to 18 cents a share. Analysts surveyed by FactSet had modeled $88.2 million in revenue and a 14-cent adjusted loss per share. Smartsheet also expects $91 million to $93 million in fiscal second-quarter billings, while the FactSet consensus was for $104.2 million. "Given uncertainties related to the ongoing novel coronavirus and resulting COVID-19...pandemic and rapidly changing global economic environment, Smartsheet is withdrawing its previously issued full-year 2021 billings and free cash flow guidance," the company said in its release. Smartsheet shares have added 13% over the past month as the S&P 500 has gained 10%.
Consolidated Water Co. Ltd. (NASDAQ Global Select Market: CWCO), a leading developer and operator of advanced water supply and treatment plants, today announced that its board of directors has approved a quarterly cash dividend of $0.085 per share.
Cybereason, a leader in endpoint protection, today announced it was named a finalist for "Best Endpoint Security Product" in the 2020 SC Awards Europe competition. This three-day virtual event concludes on Thursday, June 4, at which time several awards will be handed out, including the best solution in the endpoint security category.
Voya Financial, Inc. (NYSE: VOYA) today announced that Michael S. Smith, chief financial officer, and Matt Toms, senior managing director and chief investment officer for fixed income, Voya Investment Management, are scheduled to participate on a J.P. Morgan Life Insurance CIO Call on Thursday, June 11, 2020 at approximately 10:45 a.m. ET.
VANCOUVER , June 3, 2020 /CNW/ - Etruscus Resources Corp. (ETR.CN) (ERR.F) (the "Company" or "Etruscus") announces that, further to its news release on May 27, 2020 , the Company has closed its oversubscribed non-brokered private placement for total gross proceeds of $306,250 , consisting of 1.225 million units. Each unit was issued at a price of $0.25 and consists of one common share and one share purchase warrant exercisable at a price of $0.40 per share, entitling the holder to purchase one additional common share for a 2-year period. The Company paid a total of $525 in finder's fees at a rate of 7% of the portion of the funds raised by Leede Jones Gable Inc.
The "Enterprise Content Management Market by Component, Deployment Mode, Organization Size, Business Function (HR Operations, Procurement and Supply Chain Management), Vertical (BFSI, Transportation and Logistics), and Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
Vancouver, British Columbia--(Newsfile Corp. - June 3, 2020) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases, today announced that the Company has granted 225,000 incentive stock options to Directors, Officers and consultants exercisable at a price of $2.70 per share for a period of five years and that vest equally every three months ...